(Reuters) - Pfizer Inc will pay $55 million plus interest to settle charges that Wyeth promoted its acid reflux drug Protonix for unapproved uses and made unproven claims about the medicine, the U.S.

The bioavailability of pantoprazole when administered as a suspension in sodium bicarbonate solution and as the oral tablet was studied. In an open-label, randomized, two-period crossover study, ...

SAN FRANCISCO (MarketWatch) -- Drugmaker Wyeth said late Thursday the Food and Drug Administration approved a delayed-release oral suspension of its heartburn medication Protonix for people who cannot ...

Pantoprazole can lower how much of certain HIV drugs is absorbed, which reduces their effectiveness. When taken with warfarin, pantoprazole may increase the risk of bleeding, so your doctor might ...

Objective and design: The use of proton pump inhibitors in acid-related diseases such as peptic ulcer or erosive reflux oesophagitis is well established. The aim of the current nationwide, multicentre ...

Jubilant Pharmova announced that its subsidiary, Jubilant Generics has received a tentative approval from the USFDA US Food and Drug Administration (USFDA) for Pantoprazole Sodium delayed release oral ...